Idebenone API

Name	Idebenone
Chinese name	艾地苯醌
Cas Number	58186-27-9
Source	Italy
Qualifications	USDMF/-/-/-/-

Idebenone was first developed by Takeda Pharmaceutical Co., Ltd. of Japan. In 2005, Santhera Pharmaceuticals of Switzerland and Takeda Pharmaceuticals of Japan announced that they would jointly develop idebenone for the treatment of FRDA (Friedreich's ataxia). The first therapeutic drug, marking the drug has entered a mature stage. Idebenone has an activating effect on mitochondrial function, improves brain energy metabolism and brain dysfunction, and at the same time improves the utilization of glucose in the brain, promotes the production of ATP, and improves the metabolism of the neurotransmitter serotonin in the brain. Strong antioxidant and free radical scavenging effect. Experiments by the Anti-aging Association of Virginia in the United States have confirmed that its antioxidant effect is better than common antioxidants on the market, such as vitamin E, coenzyme Q10, and vitamin C. Studies have pointed out that idebenone can promote the intelligent rehabilitation of patients with vascular dementia and improve the quality of life of patients with vascular dementia, and its short-term efficacy is better than nimodipine.

Hot Tags: idebenone api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lercanidipine Hydrochloride API, Linagliptin API, Perindopril Tert butylamine Salt API, Ticagrelor API, Vardenafil API, Ranolazine API

• Previous: Edoxaban API
• Next: Apremilast API